Aβ low threshold mechanoreceptors contribute to sensory abnormalities in fibromyalgia - Scorecard - MDSpire

Aβ low threshold mechanoreceptors contribute to sensory abnormalities in fibromyalgia

  • By

  • Mathilde R Israel

  • Richard Berwick

  • Nisha Vastani

  • Qin Zheng

  • Warren Moore

  • Margot Maurer

  • Clive Gentry

  • Anne Marshall

  • Haoyue Sun

  • Harvey Neiland

  • James P Dunham

  • Otmane Bouchatta

  • Katy Plant

  • Saad S Nagi

  • Håkan Olausson

  • Uazman Alam

  • Xinzhong Dong

  • Stuart Bevan

  • Andrew Marshall

  • Andreas Goebel

  • David A Andersson

  • September 3, 2025

  • 0 min

Share

Clinical Scorecard: Aβ Low Threshold Mechanoreceptors Play a Role in Sensory Disturbances Associated with Fibromyalgia

At a Glance

CategoryDetail
ConditionFibromyalgia syndrome (FM)
Key MechanismsSensory abnormalities linked to sensitization of large diameter Aβ low threshold mechanoreceptors (Aβ-LTMRs) by autoreactive IgG, alongside small fibre neuropathy and nociceptor hyperexcitability
Target PopulationPeople living with fibromyalgia, predominantly women
Care SettingClinical and research settings involving sensory phenotyping and immunological assessment

Key Highlights

  • FM is characterized by widespread pain, fatigue, tactile allodynia, paraesthesia, and dysaesthesia involving both small and large sensory fibres.
  • Passive transfer of FM IgG to mice induces mechanical and cold hypersensitivity linked to sensitization of Aβ-LTMRs.
  • In people with FM, Aβ-LTMRs show altered responses to cold and mechanical stimuli, supporting a role for autoreactive IgG in sensory symptoms.

Guideline-Based Recommendations

Diagnosis

  • Consider clinical assessment of sensory abnormalities including tactile allodynia, paraesthesia, and dysaesthesia in FM patients.
  • Evaluate small fibre neuropathy via skin biopsy and electrophysiological studies focusing on C-fibre sensitization.
  • Assess presence of autoreactive IgG targeting large diameter sensory neurons as a potential biomarker.

Management

  • Address sensory symptoms by targeting peripheral sensitization mechanisms involving both small and large sensory fibres.
  • Consider immunological approaches given the role of autoreactive IgG in symptom development.
  • Incorporate multidisciplinary care addressing pain, fatigue, and sensory disturbances.

Monitoring & Follow-up

  • Monitor changes in sensory symptoms including mechanical and cold hypersensitivity over time.
  • Use clinical questionnaires and microneurography to assess sensory fibre function and treatment response.
  • Track immunological markers such as IgG reactivity to dorsal root ganglion neurons.

Risks

  • Potential for persistent sensory disturbances due to ongoing peripheral sensitization.
  • Risk of misattributing symptoms solely to small fibre neuropathy without considering large fibre involvement.
  • Challenges in managing complex sensory symptoms that impact quality of life.

Patient & Prescribing Data

Individuals diagnosed with fibromyalgia exhibiting sensory abnormalities including tactile allodynia and paraesthesia

Therapies targeting IgG-mediated sensitization of Aβ-LTMRs may alleviate mechanical and cold hypersensitivity; current evidence supports a role for immunomodulatory strategies alongside symptomatic management.

Clinical Best Practices

  • Incorporate comprehensive sensory phenotyping including assessment of both small and large fibre function.
  • Utilize passive transfer models and immunological assays to understand patient-specific IgG effects.
  • Engage patients in reporting detailed sensory experiences to guide personalized management.
  • Consider sex as a biological variable given FM predominance in females and IgG effects in both sexes.

References

Original Source(s)

Related Content